The American Psychiatric Association (APA) has updated its Privacy Policy and Terms of Use, including with new information specifically addressed to individuals in the European Economic Area. As described in the Privacy Policy and Terms of Use, this website utilizes cookies, including for the purpose of offering an optimal online experience and services tailored to your preferences.

Please read the entire Privacy Policy and Terms of Use. By closing this message, browsing this website, continuing the navigation, or otherwise continuing to use the APA's websites, you confirm that you understand and accept the terms of the Privacy Policy and Terms of Use, including the utilization of cookies.

×
ArticleNo Access

THE PREVENTION AND TREATMENT OF CHEMICAL PARKINSONISM WITH UK-738

Published Online:https://doi.org/10.1176/ajp.118.3.248

In the treatment of the long term psychotic patient who will require large amounts of phenothiazines, especially those with a piperazine ring in the side chain, consideration should be given to prevention of the EPS. UK-738 has satisfactorily suppressed these disturbing symptoms without adding undesirable side effects of its own. It has also proven to be an effective agent in the treatment of manifest chemical parkinsonism.

Access content

To read the fulltext, please use one of the options below to sign in or purchase access.